TBC1D22A is a protein encoded by the TBC1D22A gene in humans. Its name reflects its classification: TBC1 indicates that it contains a TBC (Tre-2, Bub2, and Cdc16) domain, which is typically associated with proteins that have GTPase-activating protein (GAP) activity towards small GTPases of the Rab family. The 'D22A' suffix denotes its specific gene identifier within this family.Proteins in this group, including TBC1D22A, are regulators of intracellular vesicle trafficking. They function by inactivating Rab GTPases, which play critical roles in directing vesicle transport along cytoskeletal tracks to different cellular compartments such as the Golgi apparatus, endosomes, lysosomes, and the plasma membrane. By acting as GAPs, TBC domain-containing proteins like TBC1D22A help control the timing of vesicle fusion and release, ensuring that cargo is delivered to the correct location within the cell.
The TBC1D22A protein may have specific substrates among the Rab GTPases, although the precise Rab targets and the pathways that TBC1D22A regulates are not well-characterized compared to other members of the TBC domain-containing protein family. It is likely involved in processes such as membrane trafficking, signal transduction, and cellular growth and differentiation.Mutations or dysregulation of proteins that control vesicle trafficking, like TBC1D22A, can lead to a wide array of cellular dysfunctions and are often implicated in diseases including neurological disorders, cancer, and metabolic syndromes.
VER TAMBIÉN ....
Items 1 to 10 of 11 total
Mostrar:
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
La brefeldina A altera la función del aparato de Golgi y podría afectar indirectamente a la actividad Rab GTPasa relacionada con TBC1D22A. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Le nocodazole perturbe la dynamique des microtubules, affectant le transport vésiculaire et potentiellement la fonction de TBC1D22A. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
La forskolina, al elevar los niveles de AMPc, puede modular varias vías de señalización, influyendo posiblemente en la TBC1D22A. | ||||||
9-[5-Deoxy-5-[[cis-3-[2-[6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl]ethyl]cyclobutyl](1-methylethyl)amino]-β-D-ribofuranosyl]-9H-purin-6-amine | 1380288-87-8 | sc-500607 | 50 mg | $13500.00 | ||
ML141 es un inhibidor de Cdc42, que puede afectar a vías que se cruzan con la actividad Rab GTPasa relacionada con TBC1D22A. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $148.00 $597.00 | 75 | |
El NSC23766 inhibe Rac1, lo que podría tener efectos descendentes en los procesos celulares en los que interviene TBC1D22A. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
La citochalasina D interrumpe los filamentos de actina, afectando a la morfología y el transporte celular, lo que podría afectar a TBC1D22A. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin es un inhibidor de PI3K, que influye en el tráfico de vesículas y posiblemente en la función de TBC1D22A. | ||||||
YM201636 | 371942-69-7 | sc-204193 | 5 mg | $213.00 | 6 | |
YM201636 inhibe PIKfyve, affectant le trafic endosomal, potentiellement pertinent pour les activités de TBC1D22A. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
El dinasore inhibe la dinamina, afectando a la endocitosis y al tráfico vesicular, potencialmente relevante para el TBC1D22A. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
La cloroquina, que afecta a la función endosomal y lisosomal, puede tener implicaciones en los procesos relacionados con el TBC1D22A. | ||||||